Hemagen Diagnostics Statistics
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
HMGN has 15.50 million shares outstanding.
| Current Share Class | 15.50M |
| Shares Outstanding | 15.50M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | +0.01% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.07
| Current Ratio | 1.07 |
| Quick Ratio | 0.34 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | -11.18 |
| Interest Coverage | -0.93 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -10.27% |
| Return on Invested Capital (ROIC) | -15.63% |
| Return on Capital Employed (ROCE) | -88.82% |
| Revenue Per Employee | 269,473 |
| Profits Per Employee | -60,488 |
| Employee Count | 15 |
| Asset Turnover | 1.52 |
| Inventory Turnover | 1.72 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | 0.35 |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 0.00 |
| 200-Day Moving Average | 0.01 |
| Relative Strength Index (RSI) | 24.00 |
| Average Volume (20 Days) | 20,899 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 1.65 |
Income Statement
In the last 12 months, HMGN had revenue of 4.04 million and -907,315 in losses. Loss per share was -0.06.
| Revenue | 4.04M |
| Gross Profit | 1.61M |
| Operating Income | -437,914 |
| Pretax Income | -907,315 |
| Net Income | -907,315 |
| EBITDA | -273,664 |
| EBIT | -437,914 |
| Loss Per Share | -0.06 |
Balance Sheet
The company has 66,287 in cash and 5.03 million in debt, giving a net cash position of -4.96 million or -0.32 per share.
| Cash & Cash Equivalents | 66,287 |
| Total Debt | 5.03M |
| Net Cash | -4.96M |
| Net Cash Per Share | -0.32 |
| Equity (Book Value) | -3.56M |
| Book Value Per Share | -0.23 |
| Working Capital | 145,059 |
Cash Flow
In the last 12 months, operating cash flow was -358,687 and capital expenditures -91,037, giving a free cash flow of -449,724.
| Operating Cash Flow | -358,687 |
| Capital Expenditures | -91,037 |
| Free Cash Flow | -449,724 |
| FCF Per Share | -0.03 |
Margins
Gross margin is 39.92%, with operating and profit margins of -10.83% and -22.45%.
| Gross Margin | 39.92% |
| Operating Margin | -10.83% |
| Pretax Margin | -22.45% |
| Profit Margin | -22.45% |
| EBITDA Margin | -6.77% |
| EBIT Margin | -10.83% |
| FCF Margin | n/a |
Dividends & Yields
HMGN does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.13% |
| Shareholder Yield | n/a |
| Earnings Yield | -5,670,718.75% |
| FCF Yield | -2,810,775.00% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
HMGN has an Altman Z-Score of -14.11 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -14.11 |
| Piotroski F-Score | 2 |